353 related articles for article (PubMed ID: 2684403)
1. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
3. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
4. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
Golay J; Cusmano G; Introna M
J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
[TBL] [Abstract][Full Text] [Related]
5. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
6. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
Ferrari S; Donelli A; Manfredini R; Sarti M; Roncaglia R; Tagliafico E; Rossi E; Torelli G; Torelli U
Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
[TBL] [Abstract][Full Text] [Related]
10. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation.
Honma Y; Honma C; Bloch A
Cancer Res; 1986 Dec; 46(12 Pt 1):6311-5. PubMed ID: 3465437
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
Moore DC; Carter DL; Studzinski GP
J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901
[TBL] [Abstract][Full Text] [Related]
13. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
Lyon JJ; Watson RJ
Differentiation; 1995 Oct; 59(3):171-8. PubMed ID: 7589901
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
15. Protooncogene expression in subpopulations of cells from leukemia patients.
Hulette BC; Banavali SD; Finke DP; Gopal V; Preisler HD
Cytometry; 1992; 13(6):653-8. PubMed ID: 1451597
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation.
Boise LH; Gorse KM; Westin EH
Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820
[TBL] [Abstract][Full Text] [Related]
18. Oncogenes with potential nuclear function: myc, myb and fos.
Eisenman RN; Thompson CB
Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
[TBL] [Abstract][Full Text] [Related]
19. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
